[go: up one dir, main page]

NO20015653L - Diagnose og behandling av aterosklerose og koronar hjertesykdom - Google Patents

Diagnose og behandling av aterosklerose og koronar hjertesykdom

Info

Publication number
NO20015653L
NO20015653L NO20015653A NO20015653A NO20015653L NO 20015653 L NO20015653 L NO 20015653L NO 20015653 A NO20015653 A NO 20015653A NO 20015653 A NO20015653 A NO 20015653A NO 20015653 L NO20015653 L NO 20015653L
Authority
NO
Norway
Prior art keywords
atherosclerosis
diagnosis
treatment
heart disease
coronary heart
Prior art date
Application number
NO20015653A
Other languages
English (en)
Other versions
NO20015653D0 (no
Inventor
Mahavir Singh
Zoltan Prohaszka
Gyorgy Fust
Laszlo Romics
Original Assignee
Semmeldweis University Of Medi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Semmeldweis University Of Medi filed Critical Semmeldweis University Of Medi
Publication of NO20015653D0 publication Critical patent/NO20015653D0/no
Publication of NO20015653L publication Critical patent/NO20015653L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
NO20015653A 1999-05-21 2001-11-20 Diagnose og behandling av aterosklerose og koronar hjertesykdom NO20015653L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9911772.3A GB9911772D0 (en) 1999-05-21 1999-05-21 Diagnosis and treatment of atherosclerosis
PCT/IB2000/000688 WO2000072023A2 (en) 1999-05-21 2000-05-22 Diagnosis and treatment of atherosclerosis and coronary heart disease

Publications (2)

Publication Number Publication Date
NO20015653D0 NO20015653D0 (no) 2001-11-20
NO20015653L true NO20015653L (no) 2002-01-17

Family

ID=10853840

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015653A NO20015653L (no) 1999-05-21 2001-11-20 Diagnose og behandling av aterosklerose og koronar hjertesykdom

Country Status (13)

Country Link
EP (1) EP1179182A2 (no)
JP (1) JP2003502289A (no)
KR (1) KR20020022669A (no)
CN (1) CN1351713A (no)
AU (1) AU4602500A (no)
BR (1) BR0010741A (no)
CA (1) CA2373285A1 (no)
GB (1) GB9911772D0 (no)
HU (1) HUP0201568A2 (no)
NO (1) NO20015653L (no)
RU (1) RU2001134499A (no)
WO (1) WO2000072023A2 (no)
ZA (1) ZA200109544B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030077279A1 (en) * 2001-10-24 2003-04-24 Cedars-Sinai Medical Center Methods for treating vascular disease by inhibiting toll-like receptor-4
ES2315034B1 (es) * 2004-07-02 2009-12-30 Laboratorios Indas, S.A. Proteina de choque termico 27 (hsp-27) como marcador de enfermedad cardiovascular.
CU23504A1 (es) 2004-09-24 2010-04-13 Ct Ingenieria Genetica Biotech Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
US8524453B2 (en) 2006-02-10 2013-09-03 The Brigham And Woman's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
RU2341801C2 (ru) * 2006-11-28 2008-12-20 Федеральное государственное учреждение "Федеральный центр сердца, крови и эндокринологии имени В.А. Алмазова Федерального агентства по высокотехнологичной медицинской помощи" Способ оценки эффективности антигипертензивной терапии у больных гипертонической болезнью
JP4581094B2 (ja) * 2006-12-07 2010-11-17 国立大学法人 岡山大学 動脈硬化の検査方法
EP2328911A4 (en) 2008-09-22 2012-03-14 Cedars Sinai Medical Center SHORT HUMAN MD-2 AS A NEGATIVE REGULATOR OF GREAT LIKE RECEPTOR 4 SIGNALING
US9512196B2 (en) 2008-09-22 2016-12-06 Cedars-Sinai Medical Center Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling
KR102344948B1 (ko) * 2018-09-03 2021-12-28 세종대학교산학협력단 인간 순수만능줄기세포에 특이적인 단일클론항체 n1-a4
RU2760539C1 (ru) * 2021-02-07 2021-11-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пензенский государственный университет" Способ скрининговой диагностики коронарного атеросклероза с помощью неинвазивного биомаркера-КА
KR20250040663A (ko) * 2022-07-22 2025-03-24 센트로 데 인제니에리아 제네티카 와이 바이오테크놀로지아 아포지질단백질 ai 또는 트랜스티레틴 내 문제와 연관된 질병을 치료하기 위한 펩타이드

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT398495B (de) * 1992-06-09 1994-12-27 Wick Georg Dr Diagnose oder vorhersage von atherosklerose
US5993803A (en) * 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity

Also Published As

Publication number Publication date
CA2373285A1 (en) 2000-11-30
BR0010741A (pt) 2002-02-19
CN1351713A (zh) 2002-05-29
EP1179182A2 (en) 2002-02-13
KR20020022669A (ko) 2002-03-27
WO2000072023A2 (en) 2000-11-30
HUP0201568A2 (en) 2002-08-28
GB9911772D0 (en) 1999-07-21
AU4602500A (en) 2000-12-12
RU2001134499A (ru) 2003-08-27
WO2000072023A3 (en) 2001-04-05
NO20015653D0 (no) 2001-11-20
ZA200109544B (en) 2002-06-20
JP2003502289A (ja) 2003-01-21

Similar Documents

Publication Publication Date Title
NO20034855D0 (no) Behandling og diagnose av makrofagmediert sykdom
DE60022754D1 (de) Diagnose und behandlung von arrhythmien
NO20015773D0 (no) Forhindring og behandling av amyloidogen sykdom
NO20016427L (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
NO20014769D0 (no) Preparat for behandling og diagnose av bryst cancer og fremgangsmåter for anvendelse derav
NO20002784D0 (no) Forhindring og behandling av amyloidogen sykdom
NO20022592D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
BR9600969A (pt) Método de tratamento de doença inflamatória cardíaca
DE69632601D1 (de) Auf Kodes für Herzschläge basierendes Gerät für Diagnose und Behandlung von Herzarryhythmie
NO994365D0 (no) Forutsigelse av coronararteie sykdom
NO995257D0 (no) FremgangsmÕte og materialer for diagnose og behandling av Reward Deficiency Syndrome
NO20022974D0 (no) Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
AU2002367535A1 (en) Diagnosis and treatment of vascular disease
NO20015653D0 (no) Diagnose og behandling av aterosklerose og koronar hjertelidelse
DE69837968D1 (de) Diagnose und behandlung myocardieller fehler
DE69822410D1 (de) Modularkatheter zur Abbildung und Behandlung und Montageverfahren
FR2794369B1 (fr) Traitement de la maladie de peyronie
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
ID23218A (id) Metoda pengobatan gagal jantung
AU2002326813A1 (en) Diagnosis and treatment of vascular disease
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
AU2002341880A1 (en) Diagnosis and treatment of vascular disease
AU2002341604A1 (en) Diagnosis and treatment of vascular disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application